AI assistant
BeOne Medicines Ltd. — Director's Dealing 2025
Jun 18, 2025
30073_dirs_2025-06-18_2c0c93bf-f2ef-4630-8ee7-da49598e0da5.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BeOne Medicines Ltd. (ONC)
CIK: 0001651308
Period of Report: 2025-06-16
Reporting Person: Wu Xiaobin (President and COO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-06-16 | American Depositary Shares | S | 1443 | $265.4695 | Disposed | 730 | Direct |
| 2025-06-16 | American Depositary Shares | S | 100 | $266.22 | Disposed | 630 | Direct |
| 2025-06-17 | American Depositary Shares | S | 630 | $250.8686 | Disposed | 0 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Ordinary Shares | 1246047 | Direct |
| American Depositary Shares | 12365 | Direct |
| American Depositary Shares | 4000 | Indirect |
Footnotes
F1: Each American Depositary Share represents 13 Ordinary Shares.
F2: The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of June 15, 2023, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events.
F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $265.21 to $266.01, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
F4: The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of June 16, 2021, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events.